信息
Announcement of Appointment of External Director
2026年3月25日
株式會社GEXValMarch 25, 2026 Unlocking the Value of Drug Discovery Through IP Strategy — Appointment of of Dr. Kao […]
GEXVal CTO to Present at the Annual Meeting of the PSJ
2026年3月25日
株式會社GEXValMarch 25, 2026 GEXVal CTO to Present at the 146th Annual Meeting of the Pharmaceutical Society of Ja […]
GEXVal Receives Formal PMDA Opinion Letter for Lead Program GXV-001
2026年3月24日
株式會社GEXValMarch 24, 2026 GEXVal Receives Formal PMDA Opinion Letter for Lead Program GXV-001-Post-Operative De […]
CTO Nakayama Contributes Invited Article to Experimental Medicine, Japan’s Leading Life Science Journal, on AI-Driven Drug Discovery
2026年3月12日
株式會社GEXValMarch 12, 2026 CTO Nakayama Contributes Invited Article to Experimental Medicine Special Issue on AI […]
World Rare Disease Day: GEXVal Presents Posters at 5th Tsukuba Co-creation Conference
2026年3月3日
株式會社GEXValMarch 3, 2026 World Rare Disease Day: GEXVal Presents Two Posters at 5th Tsukuba Co-creation Confere […]